Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Telix Pharmaceuticals
Biotech
Regeneron rides into radiopharma via $2.1B biobucks Telix pact
With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals.
James Waldron
Apr 13, 2026 7:24am
Heidelberg to ax 75% of staff after milestone becomes millstone
Sep 25, 2025 7:20am
Telix shows 'promising’ 13-month OS in ph. 2 brain cancer study
Apr 16, 2025 6:30am
J&J innovator vaults to Valo—Chutes & Ladders
Apr 11, 2025 8:30am
Telix pays $45M for ImaginAb's preclinical antibodies, facility
Jan 13, 2025 7:50am
Cell-focused Sana scoops first CSO—Chutes & Ladders
Aug 30, 2024 8:30am
